NCT04529070 is a NA clinical trial of Nightmare Rescripting and Rehearsal in Nightmare, sponsored by David Moss.

Who is sponsoring NCT04529070?

NCT04529070 is sponsored by David Moss.

What condition does NCT04529070 study?

NCT04529070 studies Nightmare, Sleep.

Is NCT04529070 still recruiting?

NCT04529070 is currently terminated. Last updated 18 December 2025.

Last reviewed 2025-12-18 · How we verify

NCT04529070

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nightmare Rescripting and Rehearsal

Terminated NA Last updated 18 December 2025

What this trial tests

NA trial testing Nightmare Rescripting and Rehearsal in Nightmare in 68 participants. Terminated before completion.

Timeline

21 January 2021

Primary endpoint
9 December 2025

9 December 2025

Quick facts

Lead sponsor	David Moss
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	68
Start date	21 January 2021
Primary completion	9 December 2025
Estimated completion	9 December 2025
Sites	1 location across United States

Drugs / interventions tested

Nightmare Rescripting and Rehearsal
standard of care

Conditions studied

Nightmare — all drugs for Nightmare →
Sleep — all drugs for Sleep →

Sponsor

David Moss

Who can join

18 and older, any sex, with Nightmare or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the efficacy of an abbreviated version of Imagery Rehearsal Therapy administered by non-mental health professionals in a Primary Care setting. This treatment, to be called 'Nightmare Rescripting and Rehearsal Therapy' (NRRT) would arm Primary Care medical personnel with a nonpharmacologic, ten minute intervention for treating recurring nightmares. The study will provide sleep hygiene education to both the control and experiment groups, NRRT to the experiment group only, and compare their Nightmare Distress Questionnaire and Nightmare Frequency Tool at two (2), four (4), and six (6) week intervals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nightmare

Currently open trials in the same condition.

NCT06419959 — NightWare and Cardiovascular Health in Veterans With PTSD · NA · recruiting
NCT06441864 — Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder · NA · recruiting

Other David Moss trials

Trials by the same sponsor.

NCT04692597 — Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis. · NA · terminated
NCT04236908 — Accessible Acupuncture for the Warrior With Acute Low Back Pain · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04529070 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by David Moss
Last refreshed: 18 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04529070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing